News
Swim for ELA, IDIBELL and Bellvitge Hospital, together against ALS
The association based in Cambrils visited yesterday the new IDIBELL neurological diseases laboratory and presented a generous solidarity check
New machine learning tool that predicts the evolution of OCD patients
The IDIBELL Psychiatry and Mental Health group has carried out the first study that relates clinical information with long-term prognosis through machine learning.
Alterations in the blood immune system found to increase cancer risk
An international team of researchers identifies the genetic basis and biological processes that influence cancer risk related to alterations in the number of immune cells present in blood.
IDIBELL’s scientific community will once again claim the role of women and girls in science
The event will take place at the Barradas Auditorium in L’Hospitalet de Llobregat on Thursday, February 8, at 7 p.m. In its 7th edition, the sLHam will once again be starred by six scientists from IDIBELL and two sLHamers from the Bellvitge Institute: a student and a science teacher.
Type 2 diabetes linked to increased depressive symptoms
A research team has shown how the presence of type 2 diabetes increased the likelihood of more depressive symptoms, and in turn, the higher the levels of depressive symptoms, the higher the prevalence of type 2 diabetes.
The UICEC renews its participation in the ISCIII Clinical Research Support Platform until 2026
This grant allows the UICEC to remain one of the 27 clinical research support units that make up the ISCIII platform.
Viladecans Contra el Càncer gives 35,000 euros to IDIBELL for research on melanomas, gynecological cancers and nutrition
The association based in the Baix Llobregat has been collaborating with IDIBELL since 2016, collecting funds for cancer research.
The Ministry of Science and Innovation awards €4 million for the Phase 2b clinical trial with a new drug for ischemic stroke
Collaborative success in advancing stroke neuroprotection
Environmental exposures and social determinants are key in patients with pulmonary fibrosis
The renowned Dr. Kerri Johannson, a member of the Snyder Institute for Chronic Diseases at Canada’s University of Calgary, gave an IDIBELL seminar on January 12 at the Bellvitge Campus on the impact of environmental exposures on patients with pulmonary fibrosis.